BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
PremiumPress ReleasesBetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
1M ago
BetterLife Pharma Secures Funding for Treatment Development
PremiumCompany Announcements
BetterLife Pharma Secures Funding for Treatment Development
1M ago
BetterLife Announces Closing of a Private Placement
PremiumPress Releases
BetterLife Announces Closing of a Private Placement
1M ago
BetterLife Pharma Progresses on Mental Health Therapeutics
PremiumCompany AnnouncementsBetterLife Pharma Progresses on Mental Health Therapeutics
3M ago
BetterLife Pharma Spotlights at Top Healthcare Investor Event
PremiumCompany Announcements
BetterLife Pharma Spotlights at Top Healthcare Investor Event
4M ago
BetterLife Pharma Secures Funding for BETR-001
PremiumCompany Announcements
BetterLife Pharma Secures Funding for BETR-001
4M ago
US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
PremiumPress ReleasesUS Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
9M ago
BetterLife Pharma to Host Investors Update Call on September 18, 2023
PremiumPress Releases
BetterLife Pharma to Host Investors Update Call on September 18, 2023
11M ago
BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001
PremiumPress Releases
BetterLife Obtains Favourable Animal Safety Data for Repeated Oral Dosing of BETR-001
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100